BFSG »

Janux Therapeutics shares owned by BFSG

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by BFSG from 13F filings

Historical chart of BFSG investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by BFSG consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by BFSG

Quarter filed Position value Share count Share price at filing
2024-09-30 $14k 300 45.43
2024-06-30 $17k 400 41.89

More positions owned by BFSG

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Gold Tr Ishares New (IAU)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Dimensional Etf Trust Emerging Mkts Co (DFEM)
Church & Dwight (CHD)
Raytheon Technologies Corp (RTX)
Vanguard World Energy Etf (VDE)
CSX Corporation (CSX)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Novo-nordisk A S Adr (NVO)

View all positions for BFSG

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics